Terms: = Ovarian cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR
191 results:
1. Diagnosis Shift in Site of Origin of Tubo-ovarian Carcinoma.
Lee MW; Anderson ZS; Girma AM; Klar M; Roman LD; Carlson JW; Wright JD; Sood AK; Matsuo K
Obstet Gynecol; 2024 May; 143(5):660-669. PubMed ID: 38513238
[TBL] [Abstract] [Full Text] [Related]
2. TMCO1 regulates cell proliferation, metastasis and EMT signaling through calr, promoting ovarian cancer progression and cisplatin resistance.
Sun G; Gong S; Lan S; He Y; Sun Y; Zhang Z
Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):99-109. PubMed ID: 38372107
[TBL] [Abstract] [Full Text] [Related]
3. Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target.
Li W; Huang L; Qi N; Zhang Q; Qin Z
BMC Genomics; 2024 Feb; 25(1):183. PubMed ID: 38365611
[TBL] [Abstract] [Full Text] [Related]
4. ovarian cancer survival in sub-Saharan Africa by human development index and histological subtypes: A population-based registry study.
Gizaw M; Parkin DM; Stöter O; Bukirwa P; Seife E; Chesumbai G; Korir A; Liu B; Manraj SS; Nda G; Somdyala NIM; Kantelhardt EJ
Int J Cancer; 2024 Jun; 154(11):1911-1919. PubMed ID: 38339849
[TBL] [Abstract] [Full Text] [Related]
5. Closing the diagnostic gap: Liquid biopsy potential to transform ovarian cancer outcomes in sub-Saharan Africa.
Kokori E; Olatunji G; Ogieuhi IJ; Muogbo I; Isarinade D; Ukoaka B; Ajayi I; Ezenwoba C; Samuel O; Nurudeen-Busari H; Olawade DB; Aderinto N
Medicine (Baltimore); 2024 Feb; 103(5):e37154. PubMed ID: 38306573
[TBL] [Abstract] [Full Text] [Related]
6. History of autoimmune disease and long-term survival of epithelial ovarian cancer: The extreme study.
Hannibal CG; Kjaer SK; Galanakis M; Hertzum-Larsen R; Maltesen T; Baandrup L
Gynecol Oncol; 2024 Mar; 182():1-6. PubMed ID: 38246041
[TBL] [Abstract] [Full Text] [Related]
7. Radiolabelled
Cieslik PA; Klingler S; Nolff M; Holland JP
Chemistry; 2024 Mar; 30(14):e202303805. PubMed ID: 38064536
[TBL] [Abstract] [Full Text] [Related]
8. Pregnancy After Breast cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
Lambertini M; Blondeaux E; Agostinetto E; Hamy AS; Kim HJ; Di Meglio A; Bernstein Molho R; Hilbers F; Pogoda K; Carrasco E; Punie K; Bajpai J; Ignatiadis M; Moore HCF; Phillips KA; Toss A; Rousset-Jablonski C; Peccatori FA; Renaud T; Ferrari A; Paluch-Shimon S; Fruscio R; Cui W; Wong SM; Vernieri C; Ruddy KJ; Dieci MV; Matikas A; Rozenblit M; Villarreal-Garza C; De Marchis L; Del Mastro L; Puglisi F; Del Pilar Estevez-Diz M; Rodriguez-Wallberg KA; Mrinakova B; Meister S; Livraghi L; Clatot F; Yerushalmi R; De Angelis C; Sánchez-Bayona R; Meattini I; Cichowska-Cwalinska N; Berlière M; Salama M; De Giorgi U; Sonnenblick A; Chiodi C; Lee YJ; Maria C; Azim HA; Boni L; Partridge AH;
JAMA; 2024 Jan; 331(1):49-59. PubMed ID: 38059899
[TBL] [Abstract] [Full Text] [Related]
9. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in ovarian cancer.
Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
[TBL] [Abstract] [Full Text] [Related]
10. Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium.
Petrick JL; Joslin CE; Johnson CE; Camacho TF; Peres LC; Bandera EV; Barnard ME; Beeghly A; Bethea TN; Dempsey LF; Guertin K; Harris HR; Moorman PG; Myers ER; Ochs-Balcom HM; Rosenow W; Setiawan VW; Wu AH; Schildkraut JM; Rosenberg L
Br J Cancer; 2023 Dec; 129(12):1956-1967. PubMed ID: 37865688
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in ovarian cancer Cells and a Transgenic Mouse Model of ovarian cancer.
Huang Y; Fan Y; Zhao Z; Zhang X; Tucker K; Staley A; Suo H; Sun W; Shen X; Deng B; Pierce SR; West L; Yin Y; Emanuele MJ; Zhou C; Bae-Jump V
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569750
[TBL] [Abstract] [Full Text] [Related]
12. The Association of Kidney Function and Inflammatory Biomarkers with Epithelial ovarian cancer Risk.
Hathaway CA; Townsend MK; Sklar EM; Thomas-Purcell KB; Terry KL; Trabert B; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1451-1457. PubMed ID: 37540498
[TBL] [Abstract] [Full Text] [Related]
13. Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis.
Gong W; Yu R; Cao C; Fang Y; Zhao X; Gao Q
J Ovarian Res; 2023 Jul; 16(1):136. PubMed ID: 37430376
[TBL] [Abstract] [Full Text] [Related]
14. Effect of differences in O-RADS lexicon interpretation between senior and junior sonologists on O-RADS classification and diagnostic performance.
Yang Y; Wang H; Liu Z; Su N; Gao L; Tao X; Zhang R; Gu Y; Ma L; Wang R; Xu W; Xie Y; Zhang W; Zhang H; Xue G; Ru T; Dai Q; Li J; Jiang Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12275-12283. PubMed ID: 37430161
[TBL] [Abstract] [Full Text] [Related]
15. ABRAXAS1 orchestrates BRCA1 activities to counter genome destabilizing repair pathways-lessons from breast cancer patients.
Sachsenweger J; Jansche R; Merk T; Heitmeir B; Deniz M; Faust U; Roggia C; Tzschach A; Schroeder C; Riess A; Pospiech H; Peltoketo H; Pylkäs K; Winqvist R; Wiesmüller L
Cell Death Dis; 2023 May; 14(5):328. PubMed ID: 37198153
[TBL] [Abstract] [Full Text] [Related]
16. Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors.
Mulders MCF; de Lussanet de la Sablonière QG; van Velthuysen MLF; Roes EM; Hofland J; de Herder WW
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37140986
[TBL] [Abstract] [Full Text] [Related]
17. Characterization of ovarian tissue oocytes from transgender men reveals poor calcium release and embryo development, which might be overcome by spindle transfer.
Christodoulaki A; He H; Zhou M; Cardona Barberán A; De Roo C; Chuva De Sousa Lopes SM; Baetens M; Menten B; Van Soom A; De Sutter P; Weyers S; Boel A; Stoop D; Heindryckx B
Hum Reprod; 2023 Jun; 38(6):1135-1150. PubMed ID: 37029914
[TBL] [Abstract] [Full Text] [Related]
18. Trends in the incidence of ovarian cancer in sub-Saharan Africa.
Gizaw M; Parkin DM; Stöter O; Korir A; Kamate B; Liu B; Bojang L; N'Da G; Manraj SS; Bukirwa P; Chokunonga E; Chingonzoh T; Peko JF; Finesse A; Somdyala N; Ladipo A; Kantelhardt EJ
Int J Cancer; 2023 Apr; 152(7):1328-1336. PubMed ID: 36274630
[TBL] [Abstract] [Full Text] [Related]
19. Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis.
Kim SI; Kim JH; Lee S; Cho H; van Driel WJ; Sonke GS; Bristow RE; Park SY; Fotopoulou C; Lim MC
Gynecol Oncol; 2022 Dec; 167(3):547-556. PubMed ID: 36273925
[TBL] [Abstract] [Full Text] [Related]
20. Association between fertility treatments and breast cancer risk in women with a family history or BRCA mutations: a systematic review and meta-analysis.
Liu X; Yue J; Pervaiz R; Zhang H; Wang L
Front Endocrinol (Lausanne); 2022; 13():986477. PubMed ID: 36176466
[TBL] [Abstract] [Full Text] [Related]
[Next]
